Meet Us @ ASCPT 2016 - Booth #54

ASCPT 2016 Annual Meeting

Booth #54   //   08-12 Mar. 2016   //   San Diego, CA

Spaulding Clinical Research, LLC invites you to stop by booth #54 to meet the team and learn how our paperless, 200-bed Phase I Clinic and innovative ECG Core Laboratory technology can accelerate your drug's development.  

A couple highlights you won't want to miss @ booth #54:

1)   We'll be presenting our 2015 performance Metrics
2)   A live demo of the latest ECG Core Lab Technology
3)   We'll also be raffling off an Amazon Echo.

If you can't join us, make sure to check out some of our latest content:

1)   "Characterizing QT Effect in Early Phase Oncology/Patient Studies - A New Approach"
2)   "Evaluating the Effectiveness of a Thorough QT Assessment Program"

If you are attending American Society for Clinical Pharmacology and Therapeutics (ASCPT) and would like to schedule a meeting with a Spaulding Representative, please   This email address is being protected from spambots. You need JavaScript enabled to view it.  or call us at 1-262-334-6020. Learn More

Spaulding Clinical Research, LLC Wins CRO Leadership Award

Spaulding Clinical Research, LLC (SCR) announced it has been recognized for excellence in clinical research by biopharmaceutical executives surveyed for the Life Science Leader magazine’s 2015 CRO Leadership Awards.

West Bend, WI, May 20, 2015 -- Spaulding Clinical Research, LLC (SCR) was named a two-category winner for quality and innovation for the second year in a row, based on survey responses from more than 2,300 industry executives responsible for making or influencing decisions to outsource clinical development programs to contract research organizations (CROs).

“Spaulding Clinical is honored to receive recognition from the biopharmaceutical industry for quality and innovation for the second year in a row,” said Randol Spaulding, Founder and CEO of SCR. “Innovation and quality run deep at Spaulding Clinical and these awards are a testament to our dedicated professionals and the ingenious solutions they strive for every day.”

Life Science Leader developed the annual CRO Leadership Awards in 2012 to honor top performers based on leading industry research conducted by professional market research agency Nice Insight. For this year's program, Life Science Leader narrowed the field of award winners by selecting only those companies that placed in the top 10% of each category.

About Spaulding Clinical Research, LLC

Spaulding Clinical Research, LLC (SCR) is a full-service CRO providing Phase I Drug Development and Core ECG Laboratory Services in support of studies throughout all phases of development.  SCR operates a 200-bed, fully paperless, Clinical Pharmacology Unit featuring 96, full 12-lead telemetry beds and a 12-bed unit for First-in-Human /SAD/MAD trials.

About the Awards

Life Science Leader’s readership of pharmaceutical and biopharmaceutical executives have told us about their struggles in vetting CRO partners. In response, Life Science Leader developed the CRO Leadership Awards based on industry research conducted by Nice Insight. The awards incorporate common filters used by pharma companies to vet CROs with the added filter of peer feedback. Unlike other industry awards which are given based on a voting or nomination process, the only votes that count towards the CRO Leadership Awards are those of the pharmaceutical and biopharmaceutical companies using CRO services. This helps pharma and biopharma companies focus on potential CRO partners who can handle their projects and are considered reputable in the industry.

Spaulding Clinical Research Adopts the Revolutionary ClinSpark™ eSource System

West Bend, WI, July 15, 2015-- Spaulding Clinical Research, LLC, a full-service CRO headquartered in Southeastern Wisconsin announced today that they have completed the upgrade of their eSource platform and future capabilities to use Foundry Health, LLC’s ClinSpark™ system, the world’s only CDISC ODM certified eSource solution. Spaulding Clinical utilizes the platform from subject recruitment throughout the entire study and data management processes. The significant advantages ClinSpark™ has over competing systems include:

>  The ability to communicate with potential study subjects bi-directionally with SMS (text messages)

>  Multi-site support that allows for deployment to the Cloud or to internal data centers

>  Extensive cardiac integration with both telemetry and cardiograph ECG systems

>  True bi-directional interface support of HL7, CDISC LAB, and other standards

>  Barcode sample specimen management for protocol adherence

>  Bedside device integration that facilitates automatic data collection from medical devices

>  Role-specific Dashboards for monitors, investigators or other staff that allows for clear visualizations of study progress

>  Support for traditional desktop and laptop computers in addition to mobile devices

“With the ClinSpark™ system being the only Phase I eSource system in the world to have achieved CDISC ODM certification, we have the confidence in knowing that we can speak the same language as our partners in the clinical research ecosystem. These benefits have been observed through all facets of our trials, but most heavily through shortened timelines during study startup and database locking with our biometric efforts,” stated Daniel Selness, Chief Strategy Officer at Spaulding Clinical Research. Mr. Selness continued, “I believe that the ClinSpark™ system is the only one in the world that is truly built to scale, as we need to do in our business. Its high availability architecture deployed to the trusted Cloud gives us the confidence that we need as our business continues to grow on a global scale.”

About Foundry Health

Foundry Health is a digital health company focused on building software tools that deliver creative strategic solutions. As the creators of ClinSpark™, the world’s first CDISC ODM certified Phase I eSource system, Foundry Health is driven to empower health professionals and build successful custom solutions that exceed customer needs.

About Spaulding Clinical

Spaulding Clinical Research, LLC (SCR) is a full-service CRO providing Phase I Drug Development and Core ECG Laboratory Services in support of studies throughout all phases of development.  SCR operates a 200-bed, fully paperless, Clinical Pharmacology Unit featuring 96, full 12-lead telemetry beds and a 12-bed unit for First-in-Human /SAD/MAD trials.